A case-control study on the combined effects of p53 and p73 polymorphisms on head and neck cancer risk in an Italian population

BMC Cancer

Volumn 9, Issue , 2009, Pages

  Gallì, Paola ^a   Cadoni, Gabriella ^a   Volante, Mariangela ^a   De Feo, Emma ^a   Amore, Rosarita ^a   Giorgio, Arianna ^a   Arzani, Dario ^a   Paludetti, Gaetano ^a   Ricciardi, Gualtiero ^a   Boccia, Stefania ^a  

^a CATHOLIC UNIVERSITY   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ADENINE; CYTOSINE; GUANINE; PROTEIN P53; PROTEIN P73; DNA BINDING PROTEIN; NUCLEAR PROTEIN; TUMOR SUPPRESSOR PROTEIN; TUMOR SUPPRESSOR PROTEIN P73;

ADULT; AGE DISTRIBUTION; ARTICLE; CANCER LOCALIZATION; CANCER PREVENTION; CANCER RISK; CANCER SURVIVAL; CASE CONTROL STUDY; CONTROLLED STUDY; EXON; FEMALE; GENE FUNCTION; GENE INTERACTION; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC RISK; GENETIC VARIABILITY; GENOTYPE ENVIRONMENT INTERACTION; HEAD AND NECK CARCINOMA; HETEROZYGOTE; HUMAN; HYPOPHARYNX CARCINOMA; INTRON; ITALY; LARYNX CARCINOMA; LIFESTYLE; MAJOR CLINICAL STUDY; MALE; MOUTH CARCINOMA; NUCLEIC ACID BASE SUBSTITUTION; OROPHARYNX CARCINOMA; POPULATION RISK; SQUAMOUS CELL CARCINOMA; SURVIVAL RATE; WILD TYPE; AGED; CAUCASIAN; GENETIC PREDISPOSITION; GENETICS; HEAD AND NECK TUMOR; MIDDLE AGED;

AGED; CARCINOMA, SQUAMOUS CELL; CASE-CONTROL STUDIES; DNA-BINDING PROTEINS; EUROPEAN CONTINENTAL ANCESTRY GROUP; EXONS; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HEAD AND NECK NEOPLASMS; HUMANS; INTRONS; ITALY; MALE; MIDDLE AGED; NUCLEAR PROTEINS; POLYMORPHISM, GENETIC; TUMOR SUPPRESSOR PROTEIN P53; TUMOR SUPPRESSOR PROTEINS;

EID: 66749159056     PISSN: None     EISSN: 14712407     Source Type: Journal    
DOI: 10.1186/1471-2407-9-137     Document Type: Article

References (46)

1. Pisani P Parkin DM Bray F Ferlay J Estimates of the worldwide mortality from 25 cancers in 1990 Int J Cancer 1999, 83:18-29. 10.1002/ (SICI)1097-0215(19990924)83:1<18::AID-IJC5>3.0.CO;2-M 10449602
2. Altieri A Garavello W Bosetti C Gallus S La Vecchia C Alcohol consumption and risk of laryngeal cancer Oral Oncol 2005, 41(10):956-65. 10.1016/j.oraloncology.2005.02.004 15927525
3. Hashibe M Boffetta P Zaridze D Shangina O Szeszenia-Dabrowska N Mates D Fabiánová E Rudnai P Brennan P Contribution of tobacco and alcohol to the high rates of squamous cell carcinoma of the supraglottis and glottis in Central Europe Am J Epidemiol 2007, 165(7):814-20. 10.1093/aje/kwk066 17244634
4. Tran N Rose BR O'Brien CJ Role of human papillomavirus in the etiology of head and neck cancer Head Neck 2007, 29(1):64-70. 10.1002/hed.20460 16823878
5. Boccia S Cadoni G Sayed-Tabatabaei FA Volante M Arzani D De Lauretis A Cattel C Almadori G van Duijn CM Paludetti G Ricciardi G CYP1A1, CYP2E1, GSTM1, GSTT1, EPHX1 exons 3 and 4, and NAT2 polymorphisms, smoking, consumption of alcohol and fruit and vegetables and risk of head and neck cancer J Cancer Res Clin Oncol 2008, 134(1):93-100. 10.1007/ s00432-007-0254-5 17611777
6. Pavia M Pileggi C Nobile CG Angelillo IF Association between fruit and vegetable consumption and oral cancer: A meta-analysis of observational studies Am J Clin Nutr 2006, 83(5):1126-34. 16685056
7. Jefferies S Foulkes WD Genetic mechanisms in squamous cell carcinoma of the head and neck Oral Oncol 2001, 37(2):115-26. 10.1016/ S1368-8375(00)00065-8 11167137
8. Vogelstein B Lane D Levine AJ Surfing the p53 network Nature 2000, 408(6810):307-10. 10.1038/35042675 11099028
9. Matakidou A Eisen T Houlston RS TP53 polymorphisms and lung cancer risk: a systematic review and meta-analysis Mutagenesis 2003, 18(4):377-85. 10.1093/mutage/geg008 12840112
10. Li G Sturgis EM Wang LE Chamberlain RM Amos CI Spitz MR El-Naggar AK Hong WK Wei Q Association of a p73 exon 2 G4C14-to-A4T14 polymorphism with risk of squamous cell carcinoma of the head and neck Carcinogenesis 2004, 259(10):1911-6. 10.1093/carcin/bgh197 15180941
11. Hsieh LL Huang TH Chen IH Liao CT Wang HM Lai CH Liou SH Chang JT Cheng AJ p53 polymorphisms associated with mutations in and loss of heterozygosity of the p53 gene in male oral squamous cell carcinomas in Taiwan Br J Cancer 2005, 92(1):30-5. 10.1038/sj.bjc.6602271 15583690
12. Wu X Zhao H Amos CI Shete S Makan N Hong WK Kadlubar FF Spitz MR p53 Genotypes and Haplotypes Associated With Lung Cancer Susceptibility and Ethnicity J Natl Cancer Inst 2002, 94(9):681-90. 11983757
13. McWilliams JE Evans AJ Beer TM Andersen PE Cohen JI Everts EC Henner WD Genetic polymorphisms in head and neck cancer risk Head Neck 2000, 22(6):609-17. 10.1002/ 1097-0347(200009)22:6<609::AID-HED10>3.0.CO;2-L 10941163
14. Hamel N Black MJ Ghadirian P Foulkes WD No association between p53 codon 72 polymorphism and risk of squamous cell carcinoma of the head and neck Br J Cancer 2000, 82(4):757-9. 10.1054/bjoc.1999.0993 10732740
15. Shen H Zheng Y Sturgis EM Spitz MR Wei Q p53 codon 72 polymorphism and risk of squamous cell carcinoma of the head and neck: A case-control study Cancer Lett 2002, 183(2):123-30. 10.1016/S0304-3835(02)00117-9 12065086
16. Tsai MH Lin CD Hsieh YY Chang FC Tsai FJ Chen WC Tsai CH Prognostic significance of the proline form of p53 codon 72 polymorphism in nasopharyngeal carcinoma Laryngoscope 2002, 112(1):116-9. 10.1097/ 00005537-200201000-00020 11802048
17. Wang-Gohrke S Weikel W Risch H Vesprini D Abrahamson J Lerman C Godwin A Moslehi R Olipade O Brunet JS Stickeler E Kieback DG Kreienberg R Weber B Narod SA Runnebaum IB Intron variants of the p53 gene are associated with increased risk for ovarian cancer but not in carriers of BRCA1 or BRCA2 germline mutations Br J Cancer 1999, 81(1):179-83. 10.1038/ sj.bjc.6690669 10487631
18. Sprague BL Trentham-Dietz A Garcia-Closas M Newcomb PA Titus-Ernstoff L Hampton JM Chanock SJ Haines JL Egan KM Genetic variation in TP53 and risk of breast cancer in a population-based case control study Carcinogenesis 2007, 28(8):1680-6. 10.1093/carcin/bgm097 17449902
19. Peller S Halevy A Slutzki S Kopilova Y Rotter V p53 mutations in matched primary and metastatic human tumors Mol Carcinog 1995, 13(3):166-72. 10.1002/mc.2940130306 7619219
20. Takahashi H Ichimiya S Nimura Y Watanabe M Furusato M Wakui S Yatani R Aizawa S Nakagawara A Mutation, allelotyping, and transcription analyses of the p73 gene in prostatic carcinoma Cancer Res 1998, 58(10):2076-7. 9605745
21. Nomoto S Haruki N Kondo M Konishi H Takahashi T Takahashi T Takahashi T Search for mutations and examination of allelic expression imbalance of the p73 gene at 1p36.33 in human lung cancers Cancer Res 1998, 58(7):1380-3. 9537234
22. Schabath MB Wu X Wei Q Li G Gu J Spitz MR Combined effects of the p53 and 73 polymorphisms on lung cancer risk Cancer Epidemiol Biomarkers Prev 2006, 15(1):158-61. 10.1158/1055-9965.EPI-05-0622 16434604
23. Kaghad M Bonnet H Yang A Creancier L Biscan JC Valent A Minty A Chalon P Lelias JM Dumont X Ferrara P McKeon F Caput D Monoallelically expressed gene related to p53 at 1p36, a region frequently deleted in neuroblastoma and other human cancers Cell 1997, 90(4):809-19. 10.1016/ S0092-8674(00)80540-1 9288759
24. G Wang LE Chamberlain RM Amos CI Spitz MR Wei Q p73 G4C14-to-A4T14 polymorphism and risk of lung cancer Cancer Res 2004, 64(19):6863-6. 10.1158/0008-5472.CAN-04-1804 15466174
25. Niwa Y Hirose K Matsuo K Tajima K Ikoma Y Nakanishi T Nawa A Kuzuya K Tamakoshi A Hamajima N Association of p73 G4C14-to-A4T14 polymorphism at exon 2 and p53 Arg72Pro polymorphism with the risk of endometrial cancer in Japanese subjects Cancer Lett 2005, 219(2):183-90. 10.1016/ j.canlet.2004.10.018 15723718
26. Ryan BM McManus R Daly JS Carton E Keeling PW Reynolds JV Kelleher D A common p73 polymorphism is associated with a reduced incidence of oesophageal carcinoma Br J Cancer 2001, 85(10):1499-503. 10.1054/ bjoc.2001.2066 11720435
27. Hu Z Miao X Ma H Tan W Wang X Lu D Wei Q Lin D Shen H Dinucleotide polymorphism of p73 gene is associated with a reduced risk of lung cancer in a Chinese population Int J Cancer 2005, 114(3):455-60. 10.1002/ ijc.20746 15578704
28. Sullivan A Syed N Gasco M Bergamaschi D Trigiante G Attard M Hiller L Farrell PJ Smith P Lu X Crook T Polymorphism in wild-type p53 modulates response to chemotherapy in vitro and in vivo Oncogene 2004, 23(19):3328-37. 10.1038/sj.onc.1207428 15077186
29. Wang YC Chen CY Chen SK Chang YY Lin P p53 codon 72 polymorphism in Taiwanese lung cancer patients: Association with lung cancer susceptibility and prognosis Clin Cancer Res 1999, 5(1):129-34. 9918210
30. Starinsky S Figer A Ben-Asher E Geva R Flex D Fidder HH Zidan J Lancet D Friedman E Genotype phenotype correlations in Israeli colorectal cancer patients Int J Cancer 2005, 114(1):58-73. 10.1002/ijc.20645 15523694
31. Toyama T Zhang Z Nishio M Hamaguchi M Kondo N Iwase H Iwata H Takahashi S Yamashita H Fujii Y Association of TP53 codon 72 polymorphism and the outcome of adjuvant therapy in breast cancer patients Breast Cancer Res 2007, 9:3. 1929098 17537232
32. Pfeifer D Arbman G Sun XF Polymorphism of the p73 gene in relation to colorectal cancer risk and survival Carcinogenesis 2005, 26(1):103-7. 10.1093/carcin/bgh305 15485994
33. Sobin LH Wittekind C TNM Classification of malignant tumors New York: John Wiley & Sons 5 1997.
34. Terwilliger J Ott J Handbook of Human Genetic Linkage John Hopkins University Press, Baltimore 1994.
35. Stephens M Smith NJ Donnelly P A new statistical method for haplotype reconstruction from population data Am J Hum Genet 2001, 68(4):978-89 1275651 11254454 10.1086/319501
36. Ashfield-Watt PA Welch AA Day NE Bingham SA Is 'five-a-day' an effective way of increasing fruit and vegetable intakes? Public Health Nutr 2004, 7:257-61. 10.1079/PHN2003524 15003132
37. Benjamini Y Hochberg Y Controlling the false discovery rate: A practical and powerful approach to multiple testing J Roy Statist Soc 2005, 57:289-300.
38. Lewellyn CD Johnson NW Warnakulasuriya S Risk factors for squamous cell carcinoma of the oral cavity in young people: A comprehensive literature review Oral Oncol 2001, 37:401-418. 10.1016/S1368-8375(00)00135-4 11377229
39. Hung RJ Hel van der O Tavtigian SV Brennan P Boffetta P Hashibe M Perspectives on the molecular epidemiology of aerodigestive tract cancers Mutat Res 2005, 592(1-2):102-18. 16023150
40. Garte S Gaspari L Alexandrie AK Ambrosone C Autrup H Autrup JL Baranova H Bathum L Benhamou S Boffetta P, et al Metabolic gene polymorphism frequencies in control populations Cancer Epidemiol Biomarkers Prev 2001, 10:1239-1248. 11751440
41. Rothman KJ, et al. Modern epidemiology Lippincott Williams & Wilkins 2008.
42. Mitra S Sikdar N Misra C Gupta S Paul RR Roy B Panda CK Roychoudhury S Risk assessment of p53 genotypes and haplotypes in tobacco-associated leukoplakia and oral cancer patients from eastern India Int J Cancer 2005, 117(5):786-93. 10.1002/ijc.21263 15981211
43. Buyru N Altinisik J Demokan S Dalay N p53 genotypes and haplotypes associated with risk of breast cancer Cancer Detect Prev 2007, 31(3):207-13. 10.1016/j.cdp.2007.04.004 17574348
44. Ioannidis JPA Meta-analysis in public health: Potential and problems Ital J Public Health 2006, 3:9-14.
45. Kochethu G Delgado J Pepper C Starczynski J Hooper L Krishnan S Fegan C Pratt G Two germ line polymorphisms of the tumour suppressor gene p53 may influence the biology of chronic lymphocytic leukaemia Leuk Res 2006, 30(9):1113-8. 10.1016/j.leukres.2005.12.014 16458962
46. De Feo E Persiani R La Greca A Amore R Arzani D Rausei S D'Ugo D Magistrelli P van Duijn CM Ricciardi G Boccia S A case-control study on the effect of p53 and p73 polymorphisms on gastric cancer risk and progression Mutat Res: Genet Toxicol Environ Mutagen 2009, 675(1-2):60-5. Epub 2009 Mar 3 19386249